RANI Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. (RANI) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: July 21, 2026 , by IMRAN MIR A .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| IMRAN MIR A | Director | Buy | 36,000 | $0.69 | $24.8K | 2,119,334 | |
| Imran Talat | Chief Executive Officer | Buy | 35,000 | $0.72 | $25.2K | 469,736 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.